Important Announcements

Nondiscrimination Statement Update

Boston Medical Center Health System complies with applicable Federal civil rights laws and does not discriminate on the basis of age, race, color, national origin (including limited English proficiency and primary language), religion, culture, physical or mental disabilities, socioeconomic status, sex, sexual orientation and gender identity and/or expression. BMCHS provides free aids and services to people with disabilities and free language services to people whose primary language is not English.

To see our full nondiscrimination statement, click here.

Campus Construction Update

Starting September 14, we’re closing the Menino building lobby entrance. This, along with the ongoing Yawkey building entrance closure, will help us bring you an even better campus experience that matches the exceptional care you've come to expect. Please enter the Menino and Yawkey buildings through the Moakley building, and make sure to leave extra time to get to your appointment. Thank you for your patience. 

Click here to learn more about our campus redesign. 

The Fibroid Center at Boston Medical Center will provide exceptional care to patients with uterine fibroids through a multidisciplinary, patient-centered, and evidence-based approach.

  • 70-80 percent of people with uteruses will develop uterine fibroids by age 50, of which 25-50 percent of whom will develop symptoms. 
  • Black women experience symptoms and diagnosis at an earlier age and larger, more numerous fibroids. 

Please email us at fibroidcenter@bmc.org for more information.

Fibroid Management Tool

If you have been diagnosed with uterine fibroids, this interactive tool can help you learn more about treatment options. Always talk to your doctor before starting a new treatment.

Centering Patients with Fibroids

Here at the Fibroid Center, we have adapted the CenteringPregnancy group education program developed by Centering Healthcare Institute to provide education, empowerment, and community to patients with fibroids here at BMC. Our eight-week Centering Patients with Fibroids (CPWF) program discusses topics including symptoms, treatment options, environmental factors, mental health, and patient advocacy. 

CPWF is currently rolling out as a research study funded by the federal Office on Women’s Health. We are recruiting for our final research-funded cohort to begin in October of 2024, and working with partners at BMC, Emory University/Grady Hospital in Atlanta, and fibroid nonprofit The White Dress Project to develop a long-term sustainability plan for this program.

Centering (Patients With) Fibroids Eligibility Survey

Are you between 18 and 45 years of age?

Do you have uterine fibroids with:

  • Pelvic pain
  • Heavy bleeding
  • Infertility

You may be eligible to participate in a new research study! 

Participants receive:

  • $160 for participation
  • Self-care personal kit
  • Hybrid pProgram with in-person and Zoom sessions

Take Survey

For more information about the Centering Patients with Fibroids Research Study, please e-mail Emma Forbes, program manager, at emma.forbes@bmc.org or call 857.574.9967. You can also email the team at bmcfibroidcenter@gmail.com.

The Team

Our team is comprised of gynecologists, reproductive endocrinology and infertility specialists, interventional radiologists, patients, hematologists, residents, and student researchers, and a program management specialist. Though our team is currently leading patient-centered research related to uterine fibroids at BMC, other providers within the hospital's OBGYN department are also skilled and equipped to treat patients with fibroids.

Learn more about Gynecology at BMC

Emma Forbes, MPH
Program Management Specialist
emma.forbes@bmc.org

Estefania Mudafort-Rivera, MD PGY4
Resident

Ezinnem Ugoji, MD PGY4
Resident

Abigael Olson, MD PGY1
Student Researcher

This project has been funded by the Forward for Health Equity Grant from Myovant Sciences and the Office of Women's Health, Department of Health and Human Services.